These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18817924)

  • 1. An early phase of slow myocardial activation may be necessary in order to benefit from cardiac resynchronization therapy.
    Shannon J; Navarro CO; McEntee T; Riddell G; Adgey JA; Lau EW
    J Electrocardiol; 2008; 41(6):531-5. PubMed ID: 18817924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of response to cardiac resynchronization therapy using simple electrocardiographic and echocardiographic tools.
    Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Givtaj N; Sameie N; Sadeghpour A; Haghjoo M
    Europace; 2009 Oct; 11(10):1330-7. PubMed ID: 19797149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapy.
    Gold MR; Niazi I; Giudici M; Leman RB; Sturdivant JL; Kim MH; Yu Y; Ding J; Waggoner AD
    J Cardiovasc Electrophysiol; 2007 May; 18(5):490-6. PubMed ID: 17313533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiogram-based algorithm to predict the left ventricular lead position in recipients of cardiac resynchronization systems.
    Ploux S; Bordachar P; Deplagne A; Mokrani B; Reuter S; Laborderie J; Garrigue S; Delarche N; Jais P; Haissaguerre M; Clementy J
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S2-7. PubMed ID: 19250094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of acoustic cardiography and echocardiography for optimizing pacemaker settings in cardiac resynchronization therapy.
    Zuber M; Toggweiler S; Quinn-Tate L; Brown L; Amkieh A; Erne P
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):802-11. PubMed ID: 18684276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrocardiographic optimization of interventricular delay in cardiac resynchronization therapy: a simple method to optimize the device.
    Vidal B; Tamborero D; Mont L; Sitges M; Delgado V; Berruezo A; Díaz-Infante E; Tolosana JM; Paré C; Brugada J
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1252-7. PubMed ID: 17916140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
    Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of bipolar left ventricular pacing stimulus intensity to cardiac depolarization and repolarization in humans with cardiac resynchronization devices.
    Theis C; Bavikati VV; Langberg JJ; Lloyd MS
    J Cardiovasc Electrophysiol; 2009 Jun; 20(6):645-9. PubMed ID: 19207760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term hemodynamic effects of cardiac resynchronization therapy in patients with heart failure, a narrow QRS duration, and no dyssynchrony.
    Williams LK; Ellery S; Patel K; Leyva F; Bleasdale RA; Phan TT; Stegemann B; Paul V; Steendijk P; Frenneaux M
    Circulation; 2009 Oct; 120(17):1687-94. PubMed ID: 19822812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cardiac resynchronization therapy on global and regional oxygen consumption and myocardial blood flow in patients with non-ischaemic and ischaemic cardiomyopathy.
    Lindner O; Vogt J; Kammeier A; Wielepp P; Holzinger J; Baller D; Lamp B; Hansky B; Körfer R; Horstkotte D; Burchert W
    Eur Heart J; 2005 Jan; 26(1):70-6. PubMed ID: 15615802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
    Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of cardiac resynchronization therapy in octogenarians: a comparative study with a younger population.
    Foley PW; Chalil S; Khadjooi K; Smith RE; Frenneaux MP; Leyva F
    Europace; 2008 Nov; 10(11):1302-7. PubMed ID: 18827063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous electrical and mechanical mapping using 3D cardiac mapping system: novel approach for optimal cardiac resynchronization therapy.
    Ryu K; D'Avila A; Heist EK; Rosenberg SP; Chou J; Yang M; Singh JP
    J Cardiovasc Electrophysiol; 2010 Feb; 21(2):219-22. PubMed ID: 20021519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure.
    Foley PW; Muhyaldeen SA; Chalil S; Smith RE; Sanderson JE; Leyva F
    Europace; 2009 Apr; 11(4):495-501. PubMed ID: 19307283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LV based pacing in patients with heart failure and a narrow QRS--an acute hemodynamic study.
    Dwivedi S; Sheth C; Puri A; Narain V; Saran R; Puri V
    Indian Heart J; 2007; 59(3):250-5. PubMed ID: 19124935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure.
    Ding LG; Hua W; Zhang S; Chu JM; Chen KP; Wang Y; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Mar; 122(6):617-21. PubMed ID: 19323922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of P wave dispersion after cardiac resynchronization therapy for heart failure.
    Ding L; Hua W; Zhang S; Chu J; Chen K; Wang F; Chen X
    J Electrocardiol; 2009; 42(4):334-8. PubMed ID: 19539810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alleviation of pulmonary hypertension by cardiac resynchronization therapy is associated with improvement in central sleep apnea.
    Yiu KH; Lee KL; Lau CP; Siu CW; Miu KM; Lam B; Lam J; Ip MS; Tse HF
    Pacing Clin Electrophysiol; 2008 Dec; 31(12):1522-7. PubMed ID: 19067803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cardiac resynchronization therapy on echocardiographic indices, functional capacity, and clinical outcomes of patients with a systemic right ventricle.
    Jauvert G; Rousseau-Paziaud J; Villain E; Iserin L; Hidden-Lucet F; Ladouceur M; Sidi D
    Europace; 2009 Feb; 11(2):184-90. PubMed ID: 19038975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.